Panel Discussion: Reviewing Standards & Regulatory Requirements of the Analytical Field of mRNA-Based Therapeutics

Time: 8:45 am
day: Day Two


  • Delving into how to give evidence of a state of control and maintain regulatory compliance for your mRNA analytical techniques
  • Revealing how to integrate the new novel mRNA analytical technologies to align to GMP guidelines
  • Understanding how to standardize your mRNA analytical techniques to align to CQAs and CPIs to allow efficient and rapid approval